Conclusions & Recommendations
22.7.1 - Additional fine-tuning needed regarding decision making for treatment of refugee camps/IDPs
Conclusion/Recommendation:
TEC notes that there is continued difficulty in making evidence-based decisions in the context of refugees and internally-displaced persons (IDPs), which indicates the need for clarification of the decision-making guidelines
Action:
No action required
TEC 22
2020
special populations, Zithromax® donation criteria
22.7.2 - Additional fine-tuning needed regarding decision making for treatment of refugee camps/IDPs
Conclusion/Recommendation:
The TEC considered whether a survey in a fluid population provides any actionable information; and recognizes other methodologies that allow more flexibility and context-specific data capture may be needed. The experience of other programs working in similar situations may be instructive to the trachoma community in determining the necessary indicators to allow ITI to determine the point when MDA with Zithromax® is no longer needed.
Action:
No action required
TEC 22
2020
special populations, Zithromax® donation criteria, evaluation units
22.7.3 - Additional fine-tuning needed regarding decision making for treatment of refugee camps/IDPs
Conclusion/Recommendation:
The TEC Refugee/IDP Committee will think through these issues and bring thinking to the next TEC meeting for further consideration, particularly around the issue of data gathering in these populations. The Committee is now comprised of Chad, Robin, Stephanie, and David.
Action:
A sub-committee meeting is tentatively planned for May 27th.
TEC 22
2020
special populations, evaluation units
22.8.1 - Central African Republic
Conclusion/Recommendation:
Given the lack of funding support for the Central African Republic trachoma program, TEC recommends to ITI to encourage the national program to submit a funding request to ESPEN for MDA.
Action:
The recommendation has been shared with the country
TEC 22
2020
Africa - Central/Southern
CAR
funding, recommendations for ITI management
22.9.1 - Côte d’Ivoire
Conclusion/Recommendation:
TEC recognizes the difficulty in interpreting the survey results in Korhogo, where baseline surveys were conducted at the same time as administrative redistricting resulting in a poor match of survey evaluation units and administrative districts. TEC approved the application for one round of MDA followed by impact surveys for the entirety of each of the new Korhogo districts (Korhogo 1, Korhogo 2, Dikodougou, Mbengue, Sinematiali). The TEC recommends to the NTD program of Côte d’Ivoire that impact surveys be conducted along the new administrative unit structures and not the previous survey evaluation units.
Action:
The recommendation has been shared with the country
TEC 22
2020
Africa - West
Côte d'Ivoire
evaluation unit
21.1.1 - ITI Supply Chain
Conclusion/Recommendation:
Continue to monitor actual ratio of POS and tablets reported to be administered by countries, and report back to TEC.
Action:
ITI’s Supply Chain team have collected country-by-country data on the ratio of POS and tablets used as reported by the countries, and will report on this during TEC 22.
TEC 21
2019
supply chain, recommendations for ITI management
21.2.1 - ASCEND – Crown Agents
Conclusion/Recommendation:
TEC welcomed the presentation on Crown Agents’ plans and encourages them to successfully implement without delays.
Action:
Some Requests for Proposals were released but we have not yet heard news on selection of sub-grantees.
TEC 21
2019
funding
21.2.2 - ASCEND – Crown Agents
Conclusion/Recommendation:
TEC recommends that ITI continue to invite high level representation from Crown Agents at future TEC meetings.
Action:
A representative from Crown has been invited to participate in TEC 22.
TEC 21
2019
TEC meeting management
21.3.1 - PAHO Initiative
Conclusion/Recommendation:
The TEC recognizes the challenges facing the Americas to eliminate trachoma particularly among indigenous populations in the Amazon Basin. The TEC recommends that ITI consult with PAHO to identify areas of technical and/or financial support within the ITI mandate that would support PAHO in its leadership role in trachoma elimination.
Action:
High-level visit from PAHO to The Task Force in Q1 2020 to discuss the PAHO NTD Roadmap and areas for future collaboration. It was agreed that there would be an overarching MOU between TFGH and PAHO to facilitate access to Zithromax® and technical advice.
TEC 21
2019
Americas
special populations, recommendations for ITI management
21.4.1 - Colombia
Conclusion/Recommendation:
TEC recommends that ITI send a high-level delegation to Colombia (including PAHO and TEC liaison) to discuss with the Ministry of Health the MDA strategy and delivery of the donation program, to determine:
-the baseline survey sampling frame
-the basis by which communities are targeted for treatment or excluded from treatment
-plans to evaluate program impact
-how coverage is reported
-whether the populations are static or migratory, and if migration crosses departmental or country borders
-whether funding is available for treatments and surveys
Action:
A joint PAHO-WHO-ITI visit, planned for March 2020, was postponed due to COVID-19. ITI hopes to reschedule this visit when it is safe to do so. In the interim, there is no 2021 Zithromax® Application.
TEC 21
2019
Americas
Colombia
surveys, special populations, recommendations for ITI management, suspected endemic, funding